In the following video, Fool contributor Maxxwell Chatsko talks with health care analyst Max Macaluso and recaps the latest earnings results from the pharmaceutical industry. These companies each saw healthy gains in operating results and have big upcoming launches, such as Invokana from Johnson & Johnson (NYSE: JNJ ) and Eliquis from Pfizer (NYSE: PFE ) . Nonetheless, investors will need to keep a long-term focus when viewing these complex pharmaceutical giants.
While you can certainly make huge gains in pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.